EVOLENT HEALTH INC's ticker is and the CUSIP is 30050BAF8. A total of 12 filers reported holding EVOLENT HEALTH INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $19,453,000 | +15.6% | 9,466,000 | 0.0% | 1.38% | +44.7% |
| Q2 2022 | $16,826,000 | -3.1% | 9,466,000 | 0.0% | 0.95% | +57.7% |
| Q1 2022 | $17,365,000 | +11.4% | 9,466,000 | 0.0% | 0.60% | +95.8% |
| Q4 2021 | $15,584,000 | -9.1% | 9,466,000 | 0.0% | 0.31% | -24.3% |
| Q3 2021 | $17,143,000 | – | 9,466,000 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CSS LLC/IL | 10,320,000 | $18,735,176 | 1.24% |
| DeepCurrents Investment Group LLC | 4,291,000 | $7,676,346 | 0.30% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 8,500,000 | $15,867,178 | 0.08% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,000,000 | $1,851,300 | 0.05% |
| Verition Fund Management LLC | 1,312 | $2,449,146 | 0.03% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 170,000 | $266,000 | 0.00% |